Podcasts about public health sciences

Send us a textThis week on our 'Inside the Village' podcast: Eradicated nearly three decades ago, measles cases are soaring — fuelled by COVID fatigue and misinformation that spreads faster than the virus itself.Welcome back to Inside the Village, a one-of-a-kind podcast where all news is local — and no topic is off-limits.On this week's episode: The spread of measles misinformation.Eradicated nearly 30 years ago, measles is back with a vengeance. The highly contagious virus is making a global resurgence, and Ontario is no exception.Since last October, the province has reported 1,440 cases of the disease, triggering questions about whether the Ford government is doing enough to keep residents informed — and promote vaccination.After 1998, Canada considered the disease eliminated because the vast majority of people received the measles, mumps, rubella (MMR) vaccine. But in recent years, Ontario has recorded a steep decline in vaccination rates among children under 7, with only 70 per cent immunized against measles in 2023-24.Why are so many parents refusing to have their children vaccinated against a potentially deadly virus? That is one of the many questions we asked Dr. Zahid Butt, an infectious diseases expert and professor in the School of Public Health Sciences at the University of Waterloo.If you're looking for factual information about the ongoing outbreak, this interview is a must-watch.​Inside the Village — hosted by Scott Sexsmith and Michael Friscolanti, the Editor-in-Chief of Village Media — is a news and current affairs podcast that provides a weekly window into some of the best local journalism from across our chain of Ontario newsrooms. Produced by Derek Turner, the program also explores bigger-picture issues that impact people across the province.Every episode can be found HERE. If you prefer the audio version, it is available wherever you find your favourite podcasts.Have something to say? You can reach us at itv@villagemedia.ca.Want to see more video features from Village Media? Subscribe to our YouTube channel.Reach out to us anytime: itv@villagemedia.caFollow: X, YouTube

Nicotine doesn't cause cancer—yet safer nicotine products like vapes and pouches remain under relentless attack. This, despite the role these products play in driving smoking rates to historic lows across the Western world. Why is the war on smoking turning into a war on nicotine? In this episode, Dr. Jonathan Foulds, Professor of Public Health Sciences and Psychiatry at Penn State University, joins us to unpack the contradictions at the heart of public health's approach to nicotine. We discuss the scientific evidence behind vaping and nicotine pouches, the FDA's inconsistent regulatory decisions, and how misinformation is fueling a war on harm reduction. Dr. Foulds also shares insights from his new book Treating Addiction to Tobacco and Nicotine Products, and breaks down his recent research showing that even smokers with no plans to quit can benefit from switching to lower-risk nicotine products. Only on RegWatch by RegulatorWatch.com https://youtu.be/Wfx057N6KOM Released: March 25, 2025 Produced by: Brent Stafford Make RegWatch happen, go to https://support.regulatorwatch.com #RegWatch #VapeNews

Почему раньше от гриппа можно было умереть за сутки, а теперь — всего лишь проваляться в постели неделю? Откуда берутся свиные и птичьи гриппы и кто следит за появлением новых штаммов? Как кусочки легких, сохранившиеся от солдат Первой мировой и жителей деревни на Аляске, помогли разгадать загадку испанки? В этом выпуске разбираемся, что такое инфлуэнца и почему она возвращается к нам каждый год.Информация об актуальных штаммах гриппа на сайте ВОЗ: https://worldhealthorg.shinyapps.io/flunetchart/ Партнер эпизода — швейцарский бренд натуральной косметики Weleda. Промокод ПОЧЕМУ дает скидку 30% на весь ассортимент  косметики Weleda в парфюмерной сети Золотое Яблоко при заказе онлайн в России, Беларуси и Казахстане. Он не суммируется с другими акциями, действует однократно и применить его можно до 1 августа 2025 года: https://goldapple.ru/brands/weleda?erid=2SDnje7HeHrРеклама. ООО «ВЕЛЕДА ИСТ» ИНН 7839016734Экспертка эпизода Оксана Станевич, независимый исследователь, профессор Свободного Университета (Free (Briva) University), врач-инфекционист, магистр Public Health Sciences.❤️ Поддержать студию Либо/Либо: https://support.libolibo.me/?utm_s=pmezh#donat

R. Tamara Konetzka, PhD, the Louis Block Professor of Public Health Sciences at the University of Chicago, has been studying the intersection of Medicaid home- and community-based services (HCBS) and Medicare. Her research has found that when dual eligibles use Medicaid HCBS they are more likely to use home health versus skilled nursing facilities after hospitalizations. Konetzka also is fascinated by the idea that community-initiated home health serves as a frontier for a long-term care benefit. Other areas of research for Konetzka are Medicare Advantage. She'd like to examine the use of supplemental benefits, but there is not much data available on the use of them. She speculates that the Trump administration will have a hands-off approach to MA and likely will not expand funding for HCBS.Follow us on social media:X (formerly Twitter): @McKHomeCareFacebook: McKnight's Home CareLinkedIn: McKnight's Home CareInstagram: mcknights_homecareFollow University of Chicago on social media:X (formerly Twitter): @UChicagoFacebook: The University of ChicagoLinkedIn: University of ChicagoInstagram: uchicago

The United States has announced its intention to leave the World Health Organization. What does this mean for the US, for the WHO and for campaigns to maintain global health? [ dur: 29mins. ] Sofia Gruskin is a Director of IIGH and Distinguished Professor of Population and Public Health Sciences and Law at USC. She … Continue reading Scholars' Circle – US orders withdrawal from WHO ; Jimmy Carter's Legacy – January 26, 2025 →

In this special installment of Campus Beat, we continue with our special AMS and SGPS Elections and Referenda coverage presenting footage from the January 22nd 2025 Society of Graduate and Professional Students All Candidates Debate which occurred virtually with an almost historic number of candidates running for SGPS office. Video of the debate is available on the SGPS website at SGPS.ca. The debate was also broadcast on CFRC 101.9 FM/CFRC.ca on Sunday January 26th 2025. SGPS Deputy Speaker Eileen O'Brien facilitated the January 22nd All-Candidates debate as moderator. Following Ms. O'Brien's brief introduction, we'll hear introductory remarks from SGPS Trustee Candidates Emils Matiss, a neuroscience PhD Candidate, and Nick Mertin, a graduate student transitioning from Masters to PhD in the Department of Electrical and Computer Engineering. Following their introductions, we'll hear from Vice President Community Candidate Tanya Joseph, a PhD student in the Faculty of Education, followed by VP Graduate Candidate Ali Fathi, PhD candidate in Civil Engineering and then VP Graduate candidate Ikeoluwapo Baruwa, PhD Candidate in the Faculty of Education and Surabhi Velagala, a Master's student in Public Health Sciences. Following their remarks, we will hear from the SGPS Presidential Candidate Dawood Tullah, a 2L student in the Faculty of Law student who is running unopposed followed by Oishik Bhattacharya, a Master's candidate in the Faculty of Law running for VP Finance unopposed. Then we'll hear opening remarks from three of the four VP Professional Candidates starting with Destine Lee, a 1L student in Law, followed by Megan Roth, a second year medical student, and Rit Nanda, a PhD Candidate in Environmental Studies. The fourth candidate Amir Shetaia from Electrical and Computer Engineering did not participate in the All Candidates Debate. Two VP Community Candidates Ava Fiorino and Claire Dobbie were also not present for the debate. Following each candidate's opening remarks, they will then field prepared questions from the SGPS, then field questions from SGPS members present in the virtual space, and debate with each other on those questions. Thank you for joining us here on the Campus Beat podcast for our coverage of the SGPS All Candidates debate, we hope you enjoy the program.

Send us a text In this episode of Causes or Cures, Dr. Eeks sits down with Dr. Sherlock Li to explore his recent research on the impact of forever chemicals (PFAS) on sleep, a pressing public health concern given the strong links between poor sleep and a range of health issues. Dr. Li begins by providing an overview of what forever chemicals are and how they persist in the environment and human body. He then delves into the methodology of his latest study, detailing the observed effects of PFAS on sleep patterns and the emerging theories behind these disruptions. The conversation also touches on the broader public health implications of PFAS exposure and Dr. Li's cautionary note that the replacement chemicals being introduced may not offer any improvements for our well-being. Dr. Sherlock Li, PhD, is a postdoctoral researcher in the Department of Population and Public Health Sciences at the Keck School of Medicine. You can contact Dr. Eeks at bloomingwellness.com.Follow Eeks on Instagram here.Or Facebook here.Or X.On Youtube.Or TikTok.SUBSCRIBE to her monthly newsletter here.Support the show

Host Dr. Davide Soldato and his guests Dr. Ann Wu and Dr. Alexa White discuss the article "Air Pollution and Breast Cancer Incidence in the Multiethnic Cohort Study" and the editorial "Growing Evidence for the Role of Air Pollution in Breast Cancer Development"  TRANSCRIPT The guests on this podcast episode have no disclosures to declare.  Dr. Davide Soldato: Hello and welcome to JCO After Hours, the podcast where we sit down with authors from some of the latest articles published in the Journal of Clinical Oncology. I am your host, Dr. Davide Soldato, Medical Oncologist at Ospedale San Martino in Genoa, Italy.  Today, we are joined by JCO authors Dr. Anna Wu and Dr. Alexander White. Dr. Wu is a professor of Population and Public Health Sciences at the Keck School of Medicine of UCS, while Dr. White is an investigator in the Epidemiology branch of the Environment and Cancer Epidemiology Group at the National Institute of Health.  Today, we will be discussing the article titled, “Air Pollution and Breast Cancer Incidence in the Multiethnic Cohort Study,” and the accompanying editorial.  So, thank you for speaking with us, Dr. Wu, Dr. White. Dr. Anna Wu: Thank you for having us. Dr. Alexandra White: Yes, thank you so much for the invitation to be here. Dr. Davide Soldato: So before going in depth about the results of the study that was published in the JCO, I was wondering if you could give us like a brief introduction and a little bit of background about what was known about air pollution as a risk factor for breast cancer and what was the evidence before this study was conducted. Dr. Alexandra White: Okay. I can start with that question. So, there's been research for decades looking at the relationship between air pollution and breast cancer. And it's been a really challenging question to address for a number of reasons. One being that it can be really difficult to assess exposure to air pollution and many previous studies have had really limited information on people's residences over time. But in general, what we thought leading up to this study was that evidence was most consistent that exposure to traffic related pollutants such as nitrogen dioxide was more consistently related to a higher risk of breast cancer. The evidence for fine particulate matter or PM2.5 was less consistent. More recently, there have been a few large, well conducted studies that have supported a positive association. This new study in the multiethnic cohort led by Dr. Wu is really important because it really demonstrated that, in this large study of over 50,000 women in California, that they also do see an association with PM2.5.  Dr. Davide Soldato: Thank you very much for the introduction. So, Dr. Wu, we just want to hear a little bit more about the results. So, what was the association that was observed for PM2.5? And specifically, the study that you ran was focused on a very diverse population, a multiethnic cohort, and so I was wondering if you observed any type of differences when you consider the different populations that were included in your study. And if you could also give us a little bit of what was the composition of the women that were enrolled in this cohort. Dr. Anna Wu: Thank you for the question. So, the multiethnic cohort study is a cohort of over 200,000 individuals who were enrolled when they lived in Hawaii or California. For the air pollution studies that we've been conducting, we have focused on primarily the California participants. And in this instance for the breast cancer study, it was based on roughly 56,000 individuals out of- there were about 100,000 because half of them were men and they were not included. Of the California participants, 75% of them were African Americans or Latinos and they were self-identified as these racial ethnic groups when they enrolled in the study. And this was a particularly important consideration for us because in most of the studies that have been published so far on-air pollution and breast cancer, as well as other cancer sites, most of those studies were conducted among whites in the US or whites in Europe. And even if they included non-white populations, the numbers tend to be small so that they were not able to conduct racial ethnic specific analysis. So, we were particularly interested in examining these other racial ethnic groups because we know from other studies that racial ethnic minority groups tend to live in communities of low socioeconomic status and those communities also tend to have higher levels of various types of environmental pollutants. And so, it was important for us to actually try to tease apart these various interrelated factors.  So, what we found was that per 10 micrograms per cubic meter, we had a 28% increased risk overall in all participants combined that meet across the racial ethnic groups. We actually did not see any differences or significant differences in the hazard ratios by race ethnicity and they were in general quite compatible with each other. But we did see a stronger finding among the white participants in our study. Dr. Davide Soldato: Thank you, a lot, Dr. Wu. So, I think it's very interesting the fact that in the end you observed that air pollution is a significant risk factor across all the ethnicities that were included in the study. But I think that one very strong point of the manuscript and one very strong point of the analysis was that in the end you also corrected for a series of different factors because we know that the incidence of breast cancer can be modified, for example, by familial history or BMI or smoking habits or also alcohol consumption. And a lot of these risk factors were included in your analysis. And so, I was wondering if you could tell us a little bit whether you observed any significant differences when you observed or included also these risk factors in your analysis, or whether the association for air pollution as a risk factor stands even when we consider all of these other elements. Dr. Anna Wu: Yes. So, we considered all the well-established breast cancer risk factors. And in this situation, we were particularly interested in considering smoking, alcohol intake, use of menopausal hormones, history of diabetes, body mass index, family history, as well as physical activity, because many of these risk factors, such as, for example, diabetes and body mass index, they are risk factors for breast cancer, and air pollution, have also been found to increase risk of these factors.  So, in our analysis, we first adjusted for all of these potential confounders in a mutually adjusted manner, so all of them were considered. In addition, we also conducted stratify analysis. So as an example, we stratified the analysis to examine whether the hazard ratio associated with PM2.5 provided comparable risk estimate or hazard ratio estimates for never smokers, former smokers, and current smokers. Although we did not see significant heterogeneity by these various subgroups, we did see a significantly stronger effect of PM2.5 among individuals who did not have a family history of breast cancer.  Interestingly, our finding was also stronger among individuals who were never smokers and light alcohol drinkers, even though the results were not significantly different. So, we surmised that maybe individuals who already had a high risk because of other established risk factors for breast cancer, we were less likely to be able to observe the effect of air pollution. But it's important to note that other studies, such as the ones that Dr. White has conducted, have also looked at various subgroups, and I think part of the limitation that all of us have is that once you subdivide the study population, even if you start out with a large sample size, often the sample size gets cut in half or a third. And so, we still lack the statistical power to be able to observe significant differences. But I think it is important to note that, in fact, the hazard ratio estimates are actually quite comparable, but we did see a hint of stronger effects among never smokers, and people who were light alcohol drinkers. So, I think this is an area that we certainly need to continue to investigate since there are other subgroups, such as menopausal status, such as hormone receptor status of breast cancer, that we need to consider in future studies. There's still a lot of work we need to do to sort this out, to actually figure out who are the women who are the most susceptible to the exposures. Dr. Davide Soldato: Dr. White, I would really love a comment from you on this specific area and specifically on what still needs to be done. And related to this, a question actually, for both of you, because I think that from a methodological point of view, there is a lot of work that goes into deciding how we are going to assess the exposure to air pollution. So which type of data are we going to use? Which type of data are we currently using in the epidemiological studies that have been conducted and in the one that we are discussing right now in JCO? And what are the caveats for this data that we are using? Meaning, I think that we use mostly residential addresses, which means that we are looking at the exposure where people actually live, which might not be the place where they spend most of their time. For example, if someone is working, maybe they could be more exposed and have higher exposure when they are at work compared to when they are at home. So, I was wondering if you could give us a little bit of an overview as to what is the methodological standard of care right now in terms of this analysis and what can we do better to refine and understand this specific factor as Dr. Wu was mentioning? Dr. Alexandra White: Yeah, so I'm happy to take a first stab at that question. So, I think it's important to note just how far we've come. I think even a few years ago, air pollution was really not considered a risk factor for breast cancer. And a lot of the work that we've been doing and others have really moved this forward in terms of understanding this as a risk factor. And as I mentioned earlier, there have been a lot of challenges in exposure assessment. And to get to your question, I think that our studies in general are doing better at looking at exposure over more years, residences, more time. We know that cancer takes time to develop, and we can't rely on just a single snapshot of exposure. But as you mentioned, almost all of the studies published have really exclusively focused on residential estimates of exposure. And so, there's a real need to understand the exposures that people are experiencing in other aspects of their life, from their commute to their jobs, to really capture that totality of exposure.  And then I think one of the points that Dr. Wu was alluding to as well as we know that breast cancer is a very heterogeneous disease, so risk factors for breast cancer vary by tumor subtypes, by menopausal status at diagnosis. And a lot of studies have really focused on considering breast cancer as a combined outcome, and that might be missing some really important signals where we might have a stronger effect for certain subtypes due to the fact that there's different biologic pathways that are underlying these subtypes or by menopausal status. And so having large study populations where, as we discussed earlier, would really give us the power to look among these smaller groups of women who might be more susceptible and those with younger women, we know that incidence of cancer is rising in young people, and we need to understand the risk factors for that. And most of our studies are really focused on older individuals, so I think that's one important gap, as well as having the power to really look at different differences by tumor subtypes. Dr. Davide Soldato: I think it's very interesting, and I think one point both of you made in the original article and in the accompanying editorial is also the fact that we tend to look at these risk factors in people who are actually aged, while we maybe should be looking at this in an earlier phase of development and potentially during puberty. Do you think that we should design studies that are more focused on this population even though I think that they will take a lot of time to produce significant results?  Dr. Alexandra White: Yeah. I think that it is really important to consider how exposure during early life is related to breast cancer risk. We know that exposures during pregnancy or even as early as during puberty might be particularly relevant for breast cancer. And I think a lot of our studies have really been up against the challenge of the fact that exposure monitoring for air pollution really didn't start until the 1990s. And so, it's challenging, especially for these older cohorts, to get back at that time period that might be relevant. But I think that's something that definitely newer cohorts are going to be able to address, and I think it's going to be really important, and also will give us some clues to better understand the important windows of exposure, but also that might provide clues for the biologic pathways as well that are relevant. Dr. Davide Soldato: And just a related question, because I'm not aware of this, but are there right now cohorts that are specifically looking at this in the US or in other parts of the world? If you are aware of that, of course.  Dr. Alexandra White: There have been some cohorts that have focused on exposure during these hypothesized windows of susceptibility, but I don't think they've been able to follow those women long enough to develop breast cancer. One of the things that we're working on in the sister study is trying to expand our assessment of air pollution exposure back in time to try to get at these earlier windows of exposure. So, I'm hoping that it's something we'll be able to comment on and at least for some of the women in our cohort who are younger. But I don't know, Dr. Wu, if you're familiar with any other populations that are doing this now?  Dr. Anna Wu: Well, NCI funded several new cohorts in the last couple years that are really focused on trying to get a much more refined exposure assessment. So, I know colleagues at University of Michigan that are peers and also Dr. Wei Zheng at Vanderbilt, they are putting together newer cohorts that are younger and also trying to include a range of exposure, not just air pollution, but really environmental exposures. Those cohorts I think have the potential in the future to try to address some of these questions, but again, it will take at least another number of years before there are a sufficient number of endpoints so that they can actually do these types of studies.  Another possibility is that there are a number of big cohort studies in Asia. The age of diagnosis tends to be earlier in Asia. I know that investigators in China are very interested and concerned with the air pollution effects in China. I think there are potentials that in other countries where the age of breast cancer diagnosis is actually younger than in the US and if they establish in a manner that allows them to assess air pollution that they may have opportunities.  And I think the other way to try to address this question, whether there are studies where you can actually tap into either biomarkers or pathology samples so you won't be actually studying air pollution in a large population, but you're actually narrowing it down to try to see if you see any signals in a way that would give you some additional clues and insights as to the mechanism. So I think we're going to have to piece together various types of study to try to answer the questions because one type of study like these observational air pollution studies, will allow us to address one slice of the questions that we have and then we need to put together other studies so that we can address other aspects that we're interested in to put it together. Dr. Davide Soldato: Thank you very much both of you. That was very interesting.  Coming back to the results of the manuscript, we really focused up until now on PM2.5. But it's true that inside of the study you evaluated different pollutants. So, I was wondering whether you saw a similar association for other pollutants that were included in the study or whether the association for higher risk was observed only for PM2.5. Dr. Anna Wu: The results for NO2, NOx, PM10, and carbon monoxide were actually very compatible with the risk estimates that other studies have published as well as from the meta-analysis. So, I would say that our results from the other pollutants are actually very consistent with other results. I think one difference is that our PM2.5 estimates were based on the satellite-based PM2.5 estimates, whereas all the other pollutants were based on monitoring station estimates from EPA sponsored air monitoring stations. So, they are not measured in the same way. And I think different studies over time have used either monitoring station type measures for other pollutants. And I think we were particularly interested in PM2.5 because the measurement of PM2.5 in the monitoring world didn't start until around 2000. So, studies up until that time were less able to actually provide the assessment of PM2.5 as good as we can for air pollution. There's always misclassification. So, I think it's a matter of how much misclassification in the assessment. But, again, we are really limited in really just having exposure over one part of adult life.  Dr. Davide Soldato: Thank you very much. And one potentially related question. We are speaking in general about air pollution, but I think that since we are considering residential addresses, probably we are capturing more either traffic pollution or pollution that comes from probably industries or stuff like that, which is mostly related to residential areas or the place where people live. But I think that in the end we also think about air pollution as something that can come from different forms. And one very interesting point, Dr. White, that you made in your editorial is also that there is a global change also in the way we are faced with air pollution. For example, you made the example of wildfires in your editorial and how this might potentially change exposure to air pollution, maybe for limited times, but with concentrations that are fairly higher compared to what we generally observed. So, I was wondering if you could comment a little bit on that and also, if there is potentially a way to also consider this in future epidemiological studies. Dr. Alexandra White: Yeah, so when we talk about exposure to fine particulate matter, PM2.5, we're assessing exposure to particles that are based on the size of the particle, and we're really not evaluating the types of particles that people are experiencing exposure to. And we know that, in general, that PM2.5 composition really varies geographically due to differing sources of exposure. So, like you were saying, there might be a stronger contribution to industry or from agriculture or from traffic. And so that could really change the PM2.5 exposure profile that individuals experience. And so it could be that this is another really important area that this research needs to consider, which could really help us identify what sources of exposure are most relevant.   Wildfires are a really important growing concern. We know that wildfires are increasing in both intensity and duration and frequency, and we really don't understand the long-term health impacts of wildfires. But we know that wildfire associated PM2.5 might be one of the most dominant contributors to PM2.5 moving forward. And although we've seen historic declines in PM2.5 in the US after the Clean Air Act, those declines have really stalled. PM2.5 itself is projected to increase over the next few decades, so understanding different PM2.5 composition profiles and the sources that drive them can really help us identify the most important targets for any potential interventions. And wildfire PM2.5 in particular may be of concern because it's a combustion byproduct, and so it's thought to have more of the components that might, we hypothesize, are most relevant for breast cancer, such as PAHs or polycyclic aromatic hydrocarbons or metals. And so, these components are thought to act as endocrine disruptors, which may be particularly relevant for breast cancer. So, I think understanding this changing landscape of PM2.5 moving forward is going to be really important in understanding how PM2.5 contributes to cancers beyond just breast, but as well as other female hormone driven cancers and all of the cancers really.  Dr. Davide Soldato: Thank you very much. So, one closing remark, because I think that in general, we have been really in a field of primary prevention for breast cancer where we were focusing on individual behaviors, for example, smoking cessation, reduction in alcohol intake, reduction of BMI, increase of physical activity. But I think that the evidence that is accumulating in the last three years or so is telling us more and more that we also need to shift the perspective on prevention going not only on individuals, but also as including environmental risk. So, I was wondering, how can we include this new evidence in the policies that we implement and how policymakers should act on the data that we have available right now? Dr. Anna Wu: I think it's really important that this new information is communicated to all the stakeholders, including our policymakers, so that they are, first of all, really aware that any changes and not actually adhering to current guidelines can have long lasting consequences, deleterious consequences. And I think it's important to also note that over 90% of the world actually live in areas where PM2.5 exceeds the limit. We have observed increases in breast cancer in many middle- and low-income countries, so I think it's particularly important to emphasize that this is really not just a western country issue, it is really a global issue. Dr. Alexandra White: I agree. And I would just add to that that air pollution is not something that an individual can really change on their own. There are things you can do, you can monitor air quality, you can try to live in a home that's far away from traffic. But really these are large scale problems that really require large scale solutions. And we know that policy changes can be effective here and that this is something that, in my opinion, is not something that we leave to the individual to change. This is something that we as a society should encourage change for the health of everyone. Dr. Davide Soldato: So, thank you very much again, Dr. Wu, Dr. White, for joining us today on the podcast. Dr. Anna Wu: Thank you. Dr. Alexandra White: Thank you so much for having us.  Dr. Davide Soldato: So we appreciate you sharing more on your JCO article and accompanying editorial titled, “Air Pollution and Breast Cancer Incidents in the Multiethnic Cohort Study.”  If you enjoy our show, please leave us a rating and review and be sure to come back for another episode. You can find all ASCO shows at asco.org/podcasts.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.   Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement.      

Dr. Ralph Alvarado, Commissioner of the Tennessee Department of Health and an ASTHO Member, tells us why his team decided to create an Office of Healthy Aging; Dr. Jennifer Unger, a Professor of Population and Public Health Sciences at the University of Southern California, discusses the rise of vape devices with built-in video games; and ICF is hosting a webinar about the transformative impact of recent CMS actions on Tuesday, January 7th at Noon ET. Tennessee Department of Health News Release: New Office of Healthy Aging Will Support Well-Being of Tennessee's Growing Population of Older Adults Keck School of Medicine of USC News Story: Vaping devices with video games ICF Webinar: Medicare and Medicaid move upstream to address social determinants of health ASTHO Web Page: Stay Informed  

This episode of VHHA's Patients Come First podcast features Dr. Fern Hauck, Professor of Family Medicine and Public Health Sciences at the UVA School of Medicine and Director of the International Family Medicine Clinic at UVA Health, for a conversation about her career, her recent recognition for her work with refugee families, and more. Send questions, comments, feedback, or guest suggestions to pcfpodcast@vhha.com or contact on X (Twitter) or Instagram using the #PatientsComeFirst hashtag.

In this episode, Cervivor Podcast host and cervical cancer survivor Joslyn Paguio welcomes Dr. Trisha L. Amboree from the Medical University of South Carolina to discuss the “Cervical Cancer Elimination Day of Action,” a global initiative aimed at raising awareness and mobilizing communities. They explore health disparities in cervical cancer prevention and the importance of community engagement. A special thanks to the HPV Cancer Prevention Program at St. Jude Children's Research Hospital for their partnership in this vital conversation. Join us for an inspiring discussion on creating a future free of cervical cancer! Did you connect with this episode? Share your thoughts with us on social media using #CervivorPodcast or by ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠emailing us.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠   For more Cervivor-related content, check out: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Cervivor.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Follow Cervivor on all social media platforms. If you would like to be interviewed as a potential guest for an upcoming episode or would like to request a speaker or topic for a future podcast episode, email us at info@cervivor.org. More About The Guest: Dr. Trisha Amboree is an Assistant Professor of Public Health Sciences at the Medical University of South Carolina and the Hollings Cancer Center with research training in epidemiology, health disparities, and access to and utilization of preventive healthcare services among minoritized and medically underserved populations. Much of Dr. Amboree's current research focuses on elucidating and addressing disparities in cervical cancer prevention and treatment, as well as mitigating disparate cervical cancer outcomes. --- Support this podcast: https://podcasters.spotify.com/pod/show/cervivor/support

Send us a text In this episode of Causes or Cures, Dr. Eeks sits down with Dr. Hooman Allayee and James Hilser to explore their new research on the lasting impact of COVID-19 on heart health. They reveal surprising findings about how COVID—especially in those who were hospitalized—elevates the risk of severe heart issues long after recovery, even years down the road. The conversation dives into the connection between blood type and post-COVID heart risk, and the researchers share their theories on why blood type matters. Plus, they discuss the implications of these findings for public health and clinical practice, offering important recommendations for how the public health and medical community should respond. Dr. Allayee is a professor of populations and public health sciences and biochemistry and molecular medicine at the Keck School of Medicine of USC. His research focuses on utilizing genetics and genomics to better understand complex cardiovascular, metabolic, and inflammatory diseases. James Hilser holds a masters of public health, is a bioinformatics specialist and a PhD candidate in molecular medicine in the Department of Population and Public Health Sciences at Keck School of Medicine. *New* SUBSCRIBE for Causes or Cures+ Bonus Episodes!You can contact Dr. Eeks at bloomingwellness.com.Follow Eeks on Instagram here.Or Facebook here.Or X.On Youtube.Or TikTok.SUBSCRIBE to her monthly newsletter here.Support the show

Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and interview Benjamin Toll, Medical University of South Carolina Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research and interview Professor Benjamin Toll, Medical University of South Carolina about his work and interventions to help people to quit vaping. Professor Benjamin Toll is a clinical psychologist, a professor of Public Health Sciences and Psychiatry, Co-Director of the Lung Cancer Screening Program, and Chief of Tobacco Cessation and Health Behaviors at the Hollings Cancer Center, and Director of the Tobacco Treatment Program at the Medical University of South Carolina. Ben Toll specialises in treatment of tobacco use disorders, alcohol use disorders, and improvement of health behaviours. In the September podcast Ben Tol describes how he became involved in this research field, about his smoking cessation work and about interventions to help people to quit vaping. Ben discusses some pilot studies of vaping cessation with Amanda Palmer and a study of varenicline for vaping cessation with Lisa Fucito. Ben talks about the importance of creating an evidence base to inform clinical practice guidelines for quitting vaping. At present there are very few studies looking at vaping cessation and Ben stresses the need for more studies in this field. This podcast is a companion to the electronic cigarettes Cochrane living systematic review and shares the evidence from the monthly searches. Our literature searches carried out on 1st August & 1st September found: 1 new study (10.1093/ntr/ntae158), 5 new ongoing studies (DOI: 10.51847/c5AEETRrY9; DOI: 10.1186/s13722-024-00483-5; NCT06534905; NCT06543407; NCT06554873 ) & 3 linked papers. For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 For more information on the full Cochrane review updated in January 2024 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub8/full This podcast is supported by Cancer Research UK.

Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and interview Benjamin Toll, Medical University of South Carolina Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research and interview Professor Benjamin Toll, Medical University of South Carolina about his work and interventions to help people to quit vaping. Professor Benjamin Toll is a clinical psychologist, a professor of Public Health Sciences and Psychiatry, Co-Director of the Lung Cancer Screening Program, and Chief of Tobacco Cessation and Health Behaviors at the Hollings Cancer Center, and Director of the Tobacco Treatment Program at the Medical University of South Carolina. Ben Toll specialises in treatment of tobacco use disorders, alcohol use disorders, and improvement of health behaviours. In the September podcast Ben Tol describes how he became involved in this research field, about his smoking cessation work and about interventions to help people to quit vaping. Ben discusses some pilot studies of vaping cessation with Amanda Palmer and a study of varenicline for vaping cessation with Lisa Fucito. Ben talks about the importance of creating an evidence base to inform clinical practice guidelines for quitting vaping. At present there are very few studies looking at vaping cessation and Ben stresses the need for more studies in this field. This podcast is a companion to the electronic cigarettes Cochrane living systematic review and shares the evidence from the monthly searches. Our literature searches carried out on 1st August & 1st September found: 1 new study (10.1093/ntr/ntae158), 5 new ongoing studies (DOI: 10.51847/c5AEETRrY9; DOI: 10.1186/s13722-024-00483-5; NCT06534905; NCT06543407; NCT06554873 ) & 3 linked papers. For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 For more information on the full Cochrane review updated in January 2024 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub8/full This podcast is supported by Cancer Research UK.

Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and interview Benjamin Toll, Medical University of South Carolina Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research and interview Professor Benjamin Toll, Medical University of South Carolina about his work and interventions to help people to quit vaping. Professor Benjamin Toll is a clinical psychologist, a professor of Public Health Sciences and Psychiatry, Co-Director of the Lung Cancer Screening Program, and Chief of Tobacco Cessation and Health Behaviors at the Hollings Cancer Center, and Director of the Tobacco Treatment Program at the Medical University of South Carolina. Ben Toll specialises in treatment of tobacco use disorders, alcohol use disorders, and improvement of health behaviours. In the September podcast Ben Tol describes how he became involved in this research field, about his smoking cessation work and about interventions to help people to quit vaping. Ben discusses some pilot studies of vaping cessation with Amanda Palmer and a study of varenicline for vaping cessation with Lisa Fucito. Ben talks about the importance of creating an evidence base to inform clinical practice guidelines for quitting vaping. At present there are very few studies looking at vaping cessation and Ben stresses the need for more studies in this field. This podcast is a companion to the electronic cigarettes Cochrane living systematic review and shares the evidence from the monthly searches. Our literature searches carried out on 1st August & 1st September found: 1 new study (10.1093/ntr/ntae158), 5 new ongoing studies (DOI: 10.51847/c5AEETRrY9; DOI: 10.1186/s13722-024-00483-5; NCT06534905; NCT06543407; NCT06554873 ) & 3 linked papers. For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 For more information on the full Cochrane review updated in January 2024 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub8/full This podcast is supported by Cancer Research UK.

Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and interview Benjamin Toll, Medical University of South Carolina Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research and interview Professor Benjamin Toll, Medical University of South Carolina about his work and interventions to help people to quit vaping. Professor Benjamin Toll is a clinical psychologist, a professor of Public Health Sciences and Psychiatry, Co-Director of the Lung Cancer Screening Program, and Chief of Tobacco Cessation and Health Behaviors at the Hollings Cancer Center, and Director of the Tobacco Treatment Program at the Medical University of South Carolina. Ben Toll specialises in treatment of tobacco use disorders, alcohol use disorders, and improvement of health behaviours. In the September podcast Ben Tol describes how he became involved in this research field, about his smoking cessation work and about interventions to help people to quit vaping. Ben discusses some pilot studies of vaping cessation with Amanda Palmer and a study of varenicline for vaping cessation with Lisa Fucito. Ben talks about the importance of creating an evidence base to inform clinical practice guidelines for quitting vaping. At present there are very few studies looking at vaping cessation and Ben stresses the need for more studies in this field. This podcast is a companion to the electronic cigarettes Cochrane living systematic review and shares the evidence from the monthly searches. Our literature searches carried out on 1st August & 1st September found: 1 new study (10.1093/ntr/ntae158), 5 new ongoing studies (DOI: 10.51847/c5AEETRrY9; DOI: 10.1186/s13722-024-00483-5; NCT06534905; NCT06543407; NCT06554873 ) & 3 linked papers. For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 For more information on the full Cochrane review updated in January 2024 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub8/full This podcast is supported by Cancer Research UK.

Our guest is Dr. Daniel Lin, a urologist, professor and Chief of Urologic Oncology at the University of Washington and professor of the Division of Public Health Sciences at the Fred Hutchinson Cancer Center. The goal of this podcast is to help patients and caregivers learn how prostate imaging is used to detect prostate cancer. Dr. Lin talks about prostate imaging as it relates to the American Urological Association, or AUA, clinical guidelines. Our hope is that this podcast will help patients to better talk with their doctors so they can make informed decisions about their prostate health and care. This podcast was sponsored in part by Blue Earth Diagnostics. For more information, please visit www.UrologyHealth.org and don't forget to subscribe to our free digital magazine, UrologyHealth extra® at www.urologyhealth.org/uhe. **** September 12, 2024

Dr. Erin Kobetz is Vice Provost for Research and Tenured Professor in the Departments of Medicine, Public Health Sciences, and Obstetrics and Gynecology at the University of Miami, Miller School of Medicine. Additionally, she is Associate Director of Population Science and Cancer Disparities at UM's Sylvester Comprehensive Cancer Center (SCCC), as well as, the Chief of Population Health and Cancer Disparities for UHealth Oncology Service line. Dr. Kobetz also serves as Program Director for the Community Engagement and Multidisciplinary Team Science Components of UM's Clinical Translational Science Institute (CTSA). She earned a Master's in Public Health from Rollins School of Public Health at Emory University in 1999, and joined the University of Miami in September of 2004, after completing her Ph.D. at the University of North Carolina at Chapel Hill, Gillings School of Public Health. Soon after, Dr. Kobetz established Patnè en Aksyon (Partners in Action), Sylvester's first ever campus community partnership in Little Haiti, the largest enclave of Haitian settlement, and remains committed to integrating diverse stakeholders into the translational research continuum.

Dr. Erin Kobetz is Vice Provost for Research and Tenured Professor in the Departments of Medicine, Public Health Sciences, and Obstetrics and Gynecology at the University of Miami, Miller School of Medicine. Additionally, she is Associate Director of Population Science and Cancer Disparities at UM's Sylvester Comprehensive Cancer Center (SCCC), as well as, the Chief of Population Health and Cancer Disparities for UHealth Oncology Service line. Dr. Kobetz also serves as Program Director for the Community Engagement and Multidisciplinary Team Science Components of UM's Clinical Translational Science Institute (CTSA). She earned a Master's in Public Health from Rollins School of Public Health at Emory University in 1999, and joined the University of Miami in September of 2004, after completing her Ph.D. at the University of North Carolina at Chapel Hill, Gillings School of Public Health. Soon after, Dr. Kobetz established Patnè en Aksyon (Partners in Action), Sylvester's first ever campus community partnership in Little Haiti, the largest enclave of Haitian settlement, and remains committed to integrating diverse stakeholders into the translational research continuum.

Dr. Katzmarzyk is Professor and Associate Executive Director for Population and Public Health Sciences at the Pennington Biomedical Research Center where he holds the Marie Edana Corcoran Endowed Chair in Pediatric Obesity and Diabetes. Dr. Katzmarzyk is an internationally recognized leader in the field of physical activity and obesity, with a special emphasis on pediatrics and ethnic health disparities. He has over two decades of experience in conducting large clinical and population-based studies in children and adults. He has published his research in more than 580 scholarly journals and books, and has delivered over 210 invited lectures in 16 countries. In addition to his research, Dr. Katzmarzyk plays a leading role in national health advocacy initiatives. He chairs the Research Advisory Committee for the U.S. Report Card on Physical Activity for Children and Youth for the National Physical Activity Plan Alliance. He also recently served on the 2018 U.S. Physical Activity Guidelines Advisory Committee for the U.S. Department of Health and Human Services and the World Health Organization Guideline Development Group for the WHO 2020 Guidelines on Physical Activity and Sedentary Behavior in Youth, Adults and Older Adults. In 2019 and 2020, Dr. Katzmarzyk was recognized as a highly cited researcher by the Web of Science. _____________________ This podcast episode is sponsored by Fibion Inc. | The New Gold Standard for Sedentary Behaviour and Physical Activity Monitoring Learn more about Fibion: fibion.com/research --- Collect, store, and manage SB and PA data easily and remotely - Discover new Fibion SENS Motion: https://sens.fibion.com/

Looking for the latest research in skin substitutes? You're in luck. Join Dr. Robert Kirsner as he discusses CAMPs or cellular, acellular, and matrix products. Learn about their application for chronic wounds, ulcers, conditions such as HS, and how you can use them in your clinic. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com.   Robert Kirsner, MD PHD is Chairman and the endowed Harvey Blank Professor in the Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery and Professor of Public Health Sciences at the University of Miami Miller School of Medicine. He is Chief of Dermatology at the University of Miami Hospital and Clinics and Jackson Memorial Hospital and directs the University of Miami Hospital Wound Center. His research interests include Wound Healing and Skin Cancer Epidemiology. Dr. Kirsner serves as one of 3 academic editors for the journal Wound Repair and Regeneration and on the editorial boards for a number of other journals in dermatology and wound healing. Dr. Kirsner serves in national leadership positions in both Wound Healing and Dermatology, including being Vice President of the American Academy of Dermatology and serving on the Wound Healing Society Board of Directors.   Sponsored by University of Miami Visit University of Miami's website for more information. 

Wednesday, July 10, 2024 Presenter: Dr. Claradina Soto (Navajo/Jemez Pueblo) Associate Professor at the University of Southern California Keck School of Medicine Director for the Initiative for California American Indian Health Research and Evaluation Learning Objectives/Outcomes: At the conclusion of this activity, the healthcare team will be able to: Explore the development and goals of Project SUN. Analyze the challenges and successes of implementing culturally adapted smoking cessation programs. Examine the study findings on the effectiveness of Project SUN in reducing commercial tobacco use among AI/AN youth. Discuss the importance of cultural adaptations in public health initiatives and their impact on community engagement and outcomes. Description: This presentation delves into Project SUN (Stop the Use of Nicotine), an innovative, evidence-based smoking cessation program specifically designed for American Indian/Alaska Native (AIAN) youth. Given the alarming rate of commercial tobacco use among AIAN youth—up to 42%—this program represents a critical intervention. Adapted from Project EX by Dr. Steve Sussman and further refined by Native American experts, including USC professor Claradina Soto and community consultant Lou Moerner, Project SUN integrates culturally relevant elements such as Talking Circles and distinctions between commercial and traditional tobacco use. About Dr. Soto: Dr. Claradina Soto (Navajo/Jemez Pueblo) is an Associate Professor at the University of Southern California Keck School of Medicine in the Department of Population and Public Health Sciences and the Director for the Initiative for California American Indian Health Research and Evaluation. She has over 20 years of partnering with American Indian and Alaska Native (AI/AN) populations in public health, collaborating with urban and Tribal communities in California to reduce and prevent mental health disparities, cancer prevalence, commercial tobacco use, and substance use and opioid use disorders. She teaches courses in the Master of Public Health and Health Promotion programs at USC and mentors undergraduate and graduate students. Dr. Soto is a longtime advocate for the AI/AN communities and other priority populations to advance health equity and reduce health disparities. Target audience: Physicians, nurses, health educators, administrators, and support staff working with American Indian and/or Alaska Native populations. Full webinar archive and resources: https://keepitsacred.itcmi.org/project-sun-a-culturally-adapted-youth-smoking-cessation-for-american-indian-alaska-native-youth/

In this episode of Run with Fitpage, we have the pleasure of bringing you a conversation about exercise and its role in cancer treatment - with none other than, Dr Kathryn Schmitz, who is a leading researcher in the field of exercise oncology. Dr Kathryn discusses all about exercise and its impact in cancer treatment with our host, Vikas Singh. Dr Kathryn Schmitz is a distinguished professor of public health sciences at Pennsylvania State University's College of Medicine. With a career dedicated to understanding and promoting the benefits of exercise in cancer prevention and recovery, she chaired the 2019 International Multidisciplinary American College of Sports Medicine (ACSM) Roundtable on Exercise and Cancer Prevention and Control. Under her leadership, experts from various fields reached a consensus on the pivotal role of exercise oncology, marking a significant step towards integrating exercise into standard cancer care. Dr Schmitz's extensive research has led to the publication of over 230 peer-reviewed scientific papers and has garnered $25 million in research funding since 2001. Her work includes leading multiple clinical trials and successfully translating research findings into clinical practice. Notably, she developed an online educational training program for exercise professionals and physical therapists, which has trained more than 700 outpatient rehabilitation specialists across the United States.As the lead author of the first ACSM Roundtable on Exercise for Cancer Survivors in 2010, Dr Schmitz helped establish crucial guidelines for exercise testing and prescription for cancer survivors. This guidance was further updated in an international consensus statement published in 2019. Dr Schmitz served as the president of ACSM from 2018 to 2019 and is currently the immediate past president of the organization. Her initiative, "Moving Through Cancer," aims to ensure that exercise and rehabilitation become a standard of care for all individuals living with and beyond cancer. The initiative focuses on workforce development, programming, research, and policy advocacy to achieve its mission.Click Here to Purchase Dr Kathryn's book "Running Through Cancer" About Vikas Singh:Vikas Singh, an MBA from Chicago Booth, worked at Goldman Sachs, Morgan Stanley, APGlobale, and Reliance before coming up with the idea of democratizing fitness knowledge and helping beginners get on a fitness journey. Vikas is an avid long-distance runner, building fitpage to help people learn, train, and move better.For more information on Vikas, or to leave any feedback and requests, you can reach out to him via the channels below:Instagram: @vikas_singhhLinkedIn: Vikas SinghTwitter: @vikashsingh101Subscribe To Our Newsletter For Weekly Nuggets of Knowledge!

Vaping. It seems to be everywhere these days. Sure, adults engage in vaping but, sadly, so do adolescents and even children at very high numbers. There have been all kinds of myths as they relate to vaping and, as always, it is crucial to listen to the experts who know the science. One such person is Dr. Adam Leventhal (https://keck.usc.edu/faculty-search/adam-matthew-leventhal/). Adam is a professor at Keck School of Medicine at USC where he serves as Professor of Population and Public Health Sciences as well as the Director of the Institute for Addiction Science.As his title suggests, he's the guy from whom I would want to learn and I am so grateful he shared his knowledge.So, listen in as Adam and Adam talk about vaping, the myths and realities.

Каждый день новостные редакторы N + 1 не только ищут самые интересные научные статьи, но и оценивают, насколько им можно доверять. Ведь в науке не обходится без ошибок и фальсификаций — даже издатели топовых журналов не всегда могут вовремя заподозрить неладное. В новом эпизоде подкаста редактор N + 1 Таня Мелентьева и Антон Барчук, онкоэпидемиолог, основатель магистерской программы Public Health Sciences в Университете ИТМО, говорят о том, как неспециалисты могут оценивать качество научных публикаций и стоит ли принимать решения о своем здоровье на основе новостей.Выпуск доступен везде, где вы привыкли слушать подкасты: на Яндекс.Музыке, Apple Podcasts, Google Podcasts, Звуке, Spotify.

Lida Chatzi, MD, PhD is professor of population and public health sciences in the Department of Population and Public Health Sciences at Keck School of Medicine of USC. She has more than 20 years of experience in environmental health research and a track record of research productivity in multi-disciplinary translational settings (R01s, R21s and U01) focusing on the influence of environmental chemical exposures on health outcomes by integrating human population data and experimental study designs. She has demonstrated her leadership skills as Director (USC Center for Translational Research on Environmental Health) and Deputy Director [NIEHS-funded P30 Southern California Environmental Health Science Center (SCEHSC)] in centers featuring novel bench to population team science, community engaged solution-based research, and training/career development at all stages.As a physician, epidemiologist and public health researcher, Chatzi leads an interdisciplinary program of research focused on advancing our understanding of how exposure to environmental chemicals affect metabolic health. Overall, her investigations have focused on the health effects of environmental toxicants classified as endocrine disruptors, including perfluoroalkyl substances, organochlorine pesticides, phenols, phthalates, and metals, on long-term youth health, especially, obesity, type 2 diabetes, and fatty liver disease. As Director of the USC Center for Translational Research on Environmental Health (USC-R-TEN), she is focused on understanding the influence of environmental pollutants on health outcomes by integrating human population-data and multi-omics methods to develop and comprehensive understanding of exposure risk and disease development.Learn more about this episode and others at keck.usc.edu/pphs/podcastStay in the loop - subscribe to the Preventive Dose newsletter for monthly news straight to your inbox.Follow us on social - find us at @uscpphs Instagram TikTok Facebook LinkedIn X YouTube

Ans Irfan, MD, EdD, DrPH, ScD MPH, MRPL, associate professor of population and public health sciences in the Department of Population and Public Health Sciences at Keck School of Medicine of USC, examines the role society and policies play in climate change, the need to confront the big questions, and how we might adjust our approach to improve humanity's outcome.Irfan's research questions things that are normalized within neoliberalized academy by applying the decolonial lens to re-think existing global environmental research, teaching, and practice paradigms; especially within the climate justice context. Irfan developed and teaches  PM 599: Social Dimensions of Climate Change in a Sustainable World, which introduces students to a wide range of climate health areas, including the foundations of climate science, climate justice, climate coloniality, climate vulnerability, politics of climate change, geoengineering, and climate ethics, and climate communications. His mission is for students to actively contribute to social mobilization around climate change by developing climate and science communications skills and generating public scholarship to raise awareness and mobilize climate action.Learn more about this episode and others at keck.usc.edu/pphs/podcastStay in the loop - subscribe to the Preventive Dose newsletter for monthly news straight to your inbox.Follow us on social - find us at @uscpphs Instagram TikTok Facebook LinkedIn X YouTube

Shohreh Farzan, PhD is an environmental epidemiologist, with a background in molecular biology and toxicology. Farzan's research focuses on the impact of environmental contaminants on maternal-child health, with a special interest in cardiometabolic health. Much of Farzan's work focuses on the role of environmental exposures in altering preclinical indicators of cardiovascular and metabolic disease risk, particularly during vulnerable lifestages, such as childhood and pregnancy. Within the Maternal and Developmental Risks of Environmental and Social Stressors (MADRES) study, a NIMHD-funded Center of Excellence on Environmental Health Disparities Research, she focuses on the role of prenatal air pollutants and psychosocial stressors on maternal postpartum cardiometabolic health. Farzan also leads multiple studies of the impacts of toxic metals and air pollutants on preclinical biomarkers of cardiovascular dysfunction in children and adolescents, both as PI of a NIEHS R01 to investigate the role of air pollutants in the development of atherosclerosis in the transition from childhood to young adulthood and as MPI of the ECHO LA DREAMERs study. She is also MPI of a NIEHS Research to Action R01 that established the Children's AIRE cohort to investigate environmental contributors to children's respiratory health in a rural border region of California to inform community-engaged public health actions and the recipient of a NIEHS K99/R00 Pathway to Independence Award.Connie Valencia, MPH, CHES, PhD is a Sustainability Solutions Community Engagement Fellow in the Environmental Justice Research Lab in the Department of Population and Public Health Sciences in the Keck School of Medicine of USC. Valencia is a first-generation college Latina, born and raised in Boyle Heights. She earned her BS in Psycho-bio with a minor in Chicano Studies from UCLA; Master's in Public Health with an emphasis in Environmental Health and Community Health from Cal State University Fullerton (CSUF) and PhD from the University of California Irvine (UCI) Program in Public Health. Her research is focused on understanding the role that neighborhood resources have in engaging residents in discussions on environmental health disparities through qualitative research methods. She also assess the protective role of neighborhood institutions on air pollution exposure among Hispanic/Latino ethnic enclaves through quantitative research methods. She is currently collaborating on the Imperial Valley Respiratory Health & the Environment (AIRE) study.Learn more about the USC Children's AIRE StudyLearn more about this episode and others at keck.usc.edu/pphs/podcastStay in the loop - subscribe to the Preventive Dose newsletter for monthly news straight to your inbox.Follow us on social - find us at @uscpphs Instagram TikTok Facebook LinkedIn X YouTube

It's 2024, and the opioid crisis is showing no signs of slowing down. Overdose deaths from opioids, including prescription painkillers and synthetics like fentanyl, continue to rise. The statistics paint a chilling picture.  According to the CDC, an estimated 187 people in the U.S. die every day of opioid overdoses, most involving illicit and dangerous versions of fentanyl.  What's perhaps more alarming, is this crisis is now affecting every age group. In fact, overdose is now the third leading cause of death in American children. From 2019 to 2021, adolescent overdose deaths more than doubled. To help us better understand the crisis, Dr. Ricky Bluthenthal is on the show today. At the University of Southern California, Dr. Bluthenthal is a Professor and Vice Chair for Diversity, Equity and Inclusion in the Department of Populations and Public Health Sciences, and Associate Dean for Social Justice in the Keck School of Medicine. He's well versed on the opioid crisis and its devastating effects on families and communities. He's been published more than 190 times in peer-reviewed scientific journals and is on the editorial board of the International Journal of Drug Policy. Dr. Bluthenthal has received numerous awards including the John P. McGovern Award for Excellence in Medical Education from the Association for Multidisciplinary Education & Research in Substance Use & Addiction. On this episode, he joins to give us more insight on the opioid crisis and what he believes needs to happen to make change. EPISODE SHOWNOTES: Read more. BE AFFIRMED. Get the Good Words email series. WHAT'S YOUR CAUSE? Take our quiz. STUDY SCRIPTURE. Get inside the collection. BE INSPIRED. Follow us on Instagram. FIGHT FOR GOOD. Give to The Salvation Army.

Gaining Health host, Karli Burridge, shares a few exciting updates in the field of obesity medicine and interviews Dr. Jamy Ard, The Obesity Society (TOS) President, about his personal and professional experience.  Listen as Dr. Ard shares about the positive changes in obesity care treatment, and new research they have currently underway. Bio:  Dr. Ard is professor in the Department of Epidemiology and Prevention in the Division of Public Health Sciences, co-director of the Weight Management Center and medical director of medical weight management at Wake Forest University School of Medicine in Winston-Salem, NC. He is also the current President of The Obesity Society.  In October 2021, Dr. Ard was elected as a member to the National Academy of Medicine. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.  Dr. Ard conducts research in clinical strategies to treat obesity and associated risk-factor modification. He also focuses on health disparities and ways to better engage African Americans in effective obesity treatment and research programs. He is a graduate of Duke University Medical Center in Durham, NC, where he earned his medical degree. He also holds a bachelor's of science degree in biology from Morehouse College in Atlanta, GA.LinkedIn:  Jamy ArdSupport the showThe Gaining Health Podcast will release a new episode monthly, every second Wednesday of the month. Episodes including interviews with obesity experts as well as scientific updates and new guidelines for the management of obesity.If you're a clinician or organization looking to start or optimize an obesity management program, and you want additional support and resources, check out the Gaining Health website! We offer monthly and annual Memberships, which include live group coaching, a community forum to ask questions and post resources, pre-recorded Master Classes, digital resources inlcuding patient education materials and office forms, and much more! We also sell our popular Gaining Health products, including a book on developing an obesity management program, editable forms and templates, and patient education materials in our Gaining Health Shop! If you are loving this podcast, please consider supporting us on Patreon

Gavin Macgregor-Skinner is a Senior Director at ISSA – The Worldwide Cleaning Trade Association. He has more than 30 years of technical experience in responding to infectious disease outbreaks and emergency management. He is also an Associate Professor in the Department of Public Health Sciences at Penn State College of Medicine and teaches three 15-week graduate courses on Public Health. Macgregor-Skinner has appeared on CNN, Fox News, BBC and many other news outlets to share his expertise on High Consequence Pathogens.   Steven Cooper is an engineer with a technical specialty in the research and development of water-based electrostatic spray systems. He has developed innovative core technology and commercial products related to air-atomizing induction-charging (AAIC) spray systems. Mr. Cooper is an engineer, a scientist, as well as an entrepreneur. He is the co-founder of ByoPlanet/Good Salt LLC, and has been involved in establishing several other successful companies. Mr. Cooper received his undergrad and masters degrees from the University of Georgia and has been continuously involved with the UGA Applied Electrostatics Laboratory for over three decades.

How to achieve optimal health sustainably WHILE reversing environmental devastation and getting public health policies moving in a better direction? Dr. Kayle de la Haye is quite the superhero researcher who has taken on a lot of big projects in the name of environmental and public health policy. This conversation will allow you will feel empowered and confident about action steps you can take to make a significant positive impact and improve your longevity and holistic health. Kayla de la Haye is a scientist at the University of Southern California's (USC) Center for Economic and Social Research, where she directs the Institute for Food System Equity. She works to promote health and prevent disease by applying social network analysis and systems science to key public health issues. Her research engages family and community social networks, and broader social determinants of health, to promote healthy eating, nutrition security, and prevent chronic disease. It also explores the role of social networks in group problem solving in families, teams, and coalitions. This work has been funded by the National Institutes of Health, the National Science Foundation, the U.S. Department of Defense, and the American Heart Association. Dr. de la Haye was previously an Associate Professor of Population and Public Health Sciences at USC, and worked as an Associate Behavioral/Social Scientist at the RAND Corporation. She currently serves as Vice President of the International Network of Social Network Analysis (INSNA), and in 2018, she received the INSNA Freeman Award for significant contributions to the study of social structure. She holds a Ph.D. in psychology from the University of Adelaide, Australia. Dr. de la Haye's Website: https://www.kayladelahaye.net/ I would love to connect! Instagram: https://www.instagram.com/vitamin.katie/ Website: https://katie-reines.squarespace.com/ Email: k.reines1@gmail.com Looking for personalized nutrition recommendations and accountability? Click here to apply for a free initial consultation with me: https://form.jotform.com/193528759357172 Use discount code 'VITAMINKATIE40' to save $40 on your NutriSense Continuous Glucose Monitor: https://www.nutrisense.io/ Natural fertility tracker with 99.4% accuracy at determining fertile vs non fertile days with code 'DAYSYUS+485' https://join.daysy.me/go.cgi?pid=485&... Complement Essentials use code VITAMINKATIE: https://lovecomplement.com/products/complement-essential-vegan-multivitamin LyfeFuel Recovery Shake & Adaptogenic Supplements, code VITAMINKATIE (every purchase plants trees) : https://lyfefuel.com/ Hawaiian Ceremonial Cacao from Kokoleka Collective, use discount code 'KATIELOVE' : https://www.kokolekacollective.com/

Fangqi Guo, PhD is a postdoc in the Department of Population and Public Health Sciences. Guo's current research focuses on environmental determinants of cardiovascular diseases and the individual-level behavioral and physiological processes that partially explain these environmental-health links. Her PhD research focused on the promotion of early detection of congenital heart disease among infants in underdeveloped areas. More recent analyses investigate childhood psychosocial stress and its long-term effects on cardiovascular health in adulthood. Her research takes a lifespan approach, comparing environmental-health links across life stages.Learn more about work happening in the Division of Environmental Health in the Department of Population and Public Health Sciences.Learn more about this episode and others at keck.usc.edu/pphs/podcastStay in the loop - subscribe to the Preventive Dose newsletter for monthly news straight to your inbox.Follow us on social - find us at @uscpphs Instagram TikTok Facebook LinkedIn X YouTube

David Freyer, DO, MS provides a review of hearing loss as a serious and permanent side effect caused by cisplatin chemotherapy, recent research regarding its prevention, and its relevance for young people treated for osteosarcoma.David R. Freyer, DO, MS is Professor of Clinical Pediatrics, Medicine, and Population and Public Health Sciences at the Keck School of Medicine, University of Southern California. He currently serves as Director of the Survivorship and Supportive Care Program in the Cancer and Blood Disease Institute at Children's Hospital Los Angeles, and as Director of the Cancer Survivorship Program and Co-Director of the Adolescent and Young Adult Cancer Program, both at the USC Norris Comprehensive Cancer Center. Dr. Freyer's clinical care and research are concentrated in cancer survivorship, cancer control/supportive care, and AYA oncology with interests in treatment-related toxicity, survivorship care transition, cancer care disparities, and patient-reported outcomes. He had the privilege of leading ACCL0431, a randomized Children's Oncology Group study and pivotal trial leading to FDA approval of sodium thiosulfate as the first proven agent to prevent cisplatin-induced hearing loss in young people treated for cancer.

Arts On Prescription: What if your doctor prescribed an arts-based treatment for what ails you and your health insurance paid for it. YEAH RIGHT! Actually, Yeah, right, and REALLY! In this episode we learn all about it in Arts on Prescription: A Field Guide for U. S. CommunitiesBIO'sDr. Tasha Golden directs research for the International Arts + Mind Lab at Johns Hopkins Medicine. As a national leader in arts + public health, Dr. Golden studies the impacts of arts & culture, music, aesthetics, and social norms on well-being, health research, and professional practice. She has authored many publications related to arts and health, served as an advisor on several national health initiatives, and is adjunct faculty for the University of Florida's Center for Arts in Medicine.In addition to her research, Golden is a career artist and entrepreneur. As singer-songwriter for the critically acclaimed band Ellery, she toured full-time in the U.S. and abroad, and her songs appear in feature films and TV dramas (ABC, SHOWTIME, FOX, NETFLIX, etc). She is also a published poet and has taught university courses in public health as well as in writing, rhetoric, and literature. Holding a Ph.D. in Public Health Sciences, Dr. Golden draws on her diverse background to develop innovative, interdisciplinary presentations and partnerships that advance health, health equity, creativity, and well-being.Dr. Golden is also the founder of Project Uncaged: an arts-based health intervention for incarcerated teen women that amplifies their voices in community and policy discourses. These young folx are among her greatest teachers.Jill Sonke, PhD, is director of research initiatives in the Center for Arts in Medicine at the University of Florida (UF), director of national research and impact for the One Nation/One Project initiative, and co-director of the EpiArts Lab, a National Endowment for the Arts Research Lab. She is an affiliated faculty member in the UF School of Theatre & Dance, the Norman Fixel Institute for Neurological Diseases, the Center for African Studies, the STEM Translational Communication Center, and the One Health Center, and is an editorial board member for Health Promotion Practice journal. She served in the pandemic as a senior advisor to the US Centers for Disease Control and Prevention (CDC) Vaccine Confidence and Demand Team on the COVID-19 Vaccine Confidence Task Force and currently serves on the steering committee of the Jameel Arts & Health Lab, established by the World Health Organization (WHO), the Steinhardt School at New York University, Community Jameel, and CULTURUNNERS. With 28 years of experience and leadership in the field of arts in health and a PhD in arts in public health from Ulster University in Northern Ireland, Jill is active in research and policy advocacy nationally and internationally. She is an artist and a mixed methods researcher with a current focus on population-level health outcomes associated with arts and cultural participation, arts in public health, and the arts in health communication. Notable MentionsNotable MentionsArts On Prescription: A Field Guide for US Communities.: A roadmap for communities to develop programs that integrate arts, culture, and nature resources into local health and social care systems. prescription

Professor Jasmin Tiro is a professor of Public Health Sciences at the University of Chicago She is the Associate Director of Cancer Prevention and Population Science at the NCI-Designated Comprehensive Cancer Center at the University of Chicago. Her program of research identifies multi-level determinants of cancer prevention and early detection behaviors. She uses quantitative and qualitative methods to develop, test, and implement interventions.  In 2014, Professor Tiro received the Outstanding Mentorship Award from the Center for Translational Medicine at UT Southwestern. In this episode, you will hear her share how her passion for science and experiments led her to the field of Public Health.

Today I am joined by Mary Beth Bruder, Professor of Public Health Sciences and Health Promotion, Pediatrics, and Educational Psychology at UConn and The director of Evidence Based Practice at AOTA, Susan Cahill. We discuss Early Childhood Intervention and best practices for interdisciplinary care.  Please help AOTA improve it's podcasts and the translation of research to practice and receive your contact hour for listening by completing this one-minute survey: https://forms.aota.org/forms/everyday_evidence_copy?PODCAST=Everyday Evidence: Early Childhood Competencies Additional Resources Early Childhood Personnel Center: https://ecpcta.org/cross-disciplinary-competencies/

On this week's podcast, the National Association of County and City Health Officials' Victoria Van de Vate, Director of Government Affairs, and Lauren Mastroberardino, Government Affairs Senior Specialist, provided a Congressional update on upcoming government funding challenges. They also discussed recent letters that NACCHO sent to the Office of Disease Prevention and Health Promotion on Healthy People 2030 objectives and to the Centers for Disease Control and Prevention (CDC) Division of STD Prevention about its proposed guidelines on the use of doxycycline as post-exposure prophylaxis to prevent STI transmission.    Later in the program (4:50), Timothy McCall, NACCHO's Director of Research, hosted a discussion with co-authors Rita Burke, Associate Professor of Clinical Population and Public Health Sciences and Pediatrics at the University of Southern California Keck School of Medicine; Larissa Chiari-Keith, Chief Executive Officer of Alala Advisors; and Emma Hunter, Health Emergency Preparedness Analyst at San Mateo County Health, to talk about their recently published qualitative analysis of California public health officials' experiences of harassment during COVID-19. NACCHO's Forces of Change survey found that 60% of local health departments reported their agency, leadership, and/or staff were targeted with harassment during the COVID-19 pandemic. In fact, one study found that 20% of Americans felt that harassing public health leaders was justified early in the pandemic; this rose to 25% in 2021. Even though this harassment crisis surfaced three years ago, the impacts on individuals, communities, and the public health system persist. NACCHO is drawing attention to this urgent issue. The study aimed to collect qualitative data highlighting the harrowing stories from local health officials and to better understand their experiences of harassment. The pandemic not only exposed vulnerabilities in the public health and healthcare system, but it also subjected local health officials to psychological impacts, systemic backlash, and burnout. 

Ricky N. Bluthenthal, PhD is the Associate Dean for Social Justice and a professor in the Department of Population and Public Health Sciences at Keck School of Medicine of USC. His research has established the effectiveness of syringe exchange programs, tested novel interventions and strategies to reduce HIV risk and improve HIV testing among injection drug users and men who have sex with men, documented how community conditions contribute to health disparities, and examined health policy implementation. His current studies include an observational cohort study of how cannabis legalization impacts use patterns and health outcomes of cannabis and opioids among people who inject drugs and a randomized controlled trial to test the efficacy of a single session intervention to reduce injection initiation risk behaviors among established people who inject drugs. Bluthenthal has authored or co-authored over 180 articles in peer-reviewed scientific journals such as the American Journal of Public Health, Social Science and Medicine, The Lancet, Addiction, and Alcoholism: Clinical and Experimental Research among others.Learn more about this episode and others at pphs.usc.edu/podcastStay in the loop - subscribe to the Preventive Dose newsletter for monthly news straight to your inbox.Follow us on social - find us at @uscpphs Instagram TikTok Facebook LinkedIn X YouTube

ABOUT TASHA GOLDEN, PhD:Tasha's Profile: linkedin.com/in/tashagoldenWebsites:tashagolden.com (Other)facebook/ellerymusic (Other)ellerymusic.com (Other)Twitter:goldenthisBIO:Tasha Golden, PhD is Director of Research at the International Arts+Mind Lab at Johns Hopkins University, and a national leader and consultant in arts + public health. Holding a PhD in Public Health Sciences, Tasha Golden has published extensively on the impacts of the arts, music, aesthetics, and social norms on health and well-being. She has served as an advisor on several nati      onal and international health initiatives, is adjunct faculty for the University of Florida's Center for Arts in Medicine, and recently led the pilot evaluation of CultureRx in Massachusetts: the first arts-on-prescription in the U.S.Golden is also a career artist and entrepreneur. As singer-songwriter for the critically acclaimed band Ellery, she toured full-time in the US and abroad, and her songs appear in feature films and TV dramas (ABC, SHOWTIME, FOX, NETFLIX, etc). She is a published poet (Humanist Press) and founder of Project Uncaged: an arts-based health intervention for incarcerated teen women that amplifies their voices in justice reform.Tasha's diverse background drives her success as an international speaker and thought leader. She gives talks and facilitates workshops for artists, businesses, researchers, practitioners, and more—helping them enhance and reimagine their work. As a consultant, she helps leaders and organizations draw on the science of arts and health to further their goals. This is one of those conversations that literally just scratches the surface of what is possible when considering how the arts influences our lives. It is an important conversation about why  we need to put art back into our daily routines as a prescription to wellbeing. SHOW INTRO: Welcome to episode 61 of the NXTLVL Experience Design podcast. These dynamic dialogues based on our acronym DATA - design, architecture, technology, and the arts crosses over disciplines but maintains a common thread of people who are passionate about the world we live in and human's influence on it, the ways we craft the built environment to maximize human experience, increasing our understanding of human behavior and searching for the New Possible.As usual, thanks go to VMSD magazine and Smartwork Media.VMSD is the publisher of VMSD magazine and brings us, in the brand experience world, the International Retail Design Conference. The IRDC is one of the best retail design conferences that there is bringing together the world of retailers, brands and experience place makers every year for two days of engaging conversations and pushing the discourse forward on what makes retailing relevant.You will find the archive of the NXTLVL Experience Design podcast on VMSD.com.Thanks also goes to Shop Association the only global retail trade association dedicated to elevating the in-store experience. SHOP Association represents companies and affiliates from 25 countries and brings value to their members through research, networking, education, events and awards. Check then out on SHOPAssociation.orgIn a minute, we'll dig into my discussion with Tasha Golden - Director of Research at the International Arts+Mind Lab at Johns Hopkins University.But first a few thoughts to set up our talk…****************Art and making is part of our human experience – it is part of who we are as a species.I have had this feeling for a number of years, and probably expressed it on this podcast a number of times, that art and making are intrinsic to all of us. There's something unique about the making of things that humans do that is different than other living creatures on the planet. Sure, some of the animals in our world make things too. Birds make nests and the great apes do as well, for some apes, new ones every night as I understand it. But the defining feature between humans and the other creatures making things on the planet is that we make things that can make other things.We are Homo Sapiens – “Man The Thinker” but we are also “Homo Faber” or Man The Maker. I think we're equally “Homo Ludens” – “Man The Player.”I'm sure that there's some deep connection between the idea of the making of things and play that are also deeply connected in defining who we are and how we come to understand ourselves and navigate the world. When I am deeply connected to the making of things, specifically when listening to music and painting, I am very aware of the fact that I am in a Flow state that feels like being deeply involved in play. Time disappears, dissipates… its otherworldly. I think that making, whether objects, stories, music or other manifestations of our creative minds is part of who we all are. But I also think we have pushed it aside getting up in our rational heads believing that we could think our way through our lives rather than feeling, or maybe even creating our way through them.Sir Ken Robinson had said something like ‘we are all born creative, and we have it educated out of us.' That's a tragedy with huge implications to our world when I think we really need super creative solutions to life's pressing challenges.It seems to me that creativity was a necessary skill to be developed as part of our evolutionary history. Being creative, a good problem solver, was an insurance policy for survival. This is also true of our ability to engage in empathic relationships in collaborative communities. When working together, we were much better able to survive. Millenia ago, being cast out of the group and having to go at on your own in the wild might have significantly reduced your chances of survival.And so, making and creating close knit social communities and problem solving have been with us from time immemorial.But beyond making tools, creating shelters and being creative in these ways so as to survive in an unpredictable and sometime brutal world, the arts, at least we call them now evolved as a way for us to express ourselves, our ideological orientations, our understanding of the world.In some ways they were an attempt to understand and answer some of the existential questions of what it meant to be human and how we fit into the cosmological scheme of things. The arts in its many forms; sculpture, dance, song, music, and later literature, brought communities together in shared understanding of the meaning of being individuals as well as members of a larger whole. The arts were a vehicle for the expression of ideas, the asking of questions and searching for answers. In many ways the arts helped to express the ineffable. The arts aligned with our penchant for using narratives to navigate through the world. Stories put things into place, they described the why and how of things. Cognitive scientist Roger Schank has said “Humans are not ideally set up to understand logic; they're ideally set up to understand stories.”      And many of the stories we tell are in the form of the arts. From the paintings on the walls of caves in Lascaux France 1700 years ago, to the contemporary dance of Martha Graham, to best-selling books (you pick the author) or immersive digital experiences of media artists like Refik Anadol, the arts have been, and continue to be, part of our lives. Without the arts, life would be bereft of meaning.I have often heard people say I can't draw or I've got no rhythm and can't dance or I can't hold a tune. These self-judgmental comments go completely contrary to what we know from science about the value of engaging in art or even doing simple things like humming your favorite tune and the positive effects it has on your mind-body state.I find myself humming or singing to myself all the time – Christmas carols in the summer, old 70's rock classics any day, doesn't matter. Humming, an ancient artform, plays a key role in activating the parasympathetic nervous system – also known as your ‘rest and digest state'. Because your vagus nerve, one of your neural superhighways connecting your brain to major organs in the rest of your body, runs through your larynx and pharynx in your throat, the vibrations that humming stimulates your vagus nerve and creates what's known as “vagal tone.”Humming can also improve heart rate variability which is an important metric that shows how well you can recover from experiences of stress. So, when you hum you induce something called “parasympathetic dominance” which means that you move from a fight or flight state into one of increased relaxation. The idea here is that bringing the arts into our lives even in the simplest of ways like humming, reconnects us to ourselves and helps support mind body health, an overall sense of well-being. More and more research is pointing to the fact that engaging in the arts and having a sense of well-being can be directly connected. In fact the whole emerging field in cognitive science called neuroaesthetics is geared towards the understanding of how the arts, in all of their incarnations, influences how we feel - not just when listening to a piece of music or staring at a painting on a wall in a museum - but how the    overall built environment potentially influences our emotional state which may have a direct effect on our body systems potentially leading to disease. So, there is a significant problem at hand when arts funding is slashed from school curricula thinking that it is less important than getting our school aged children ready to compete on the world stage by simply focusing on STEM based curricula only. Fully integrating the arts into the school, and even our workdays, increases learning and company performance. As a personal example, I know I've described this in a number of the podcast episodes, and at the risk of being repetitive I'll do so       now……during the pandemic between 2020 and 2022 and I poured myself into painting, writing and doing this podcast all of which would qualify as the arts. I firmly believe that if it weren't for me finding a Flow state, a pseudo meditative experience, through painting and listening to music while doing it , that my experience of the pandemic may have been drastically different. I think that in many ways, it might have actually been quite negative and that I might have been a very difficult person to live with. Instead, art gave me a sense of agency to be able to navigate the ambiguity of an uncertain future. Engaging in the arts, if even on a small plain of my physical world in the form of a 36 by 48-inch canvas, gave me a certain sense of control. I shifted the negative energy of anxiety and fear of the unknown into creativity in the form of a pandemic production of 25 canvases. I was directly exposed to the value and impact of how the arts could be harnessed to create a profound sense of well-being.And this brings me to my guest Tasha Golden.    Tasha Golden, PhD is Director of Research at the International Arts+Mind Lab at Johns Hopkins University, and a national leader and consultant in arts + public health. Holding a PhD in Public Health Sciences, Tasha Golden has published extensively on the impacts of the arts, music, aesthetics, and social norms on health and well-being. She has served as an advisor on several nati      onal and international health initiatives, is adjunct faculty for the University of Florida's Center for Arts in Medicine, and recently led the pilot evaluation of CultureRx in Massachusetts: the first arts-on-prescription in the U.S.Golden is also a career artist and entrepreneur. As singer-songwriter for the critically acclaimed band Ellery, she toured full-time in the US and abroad, and her songs appear in feature films and TV dramas (ABC, SHOWTIME, FOX, NETFLIX, etc). She is a published poet (Humanist Press) and founder of Project Uncaged: an arts-based health intervention for incarcerated teen women that amplifies their voices in justice reform.Tasha's diverse background drives her success as an international speaker and thought leader. She gives talks and facilitates workshops for artists, businesses, researchers, practitioners, and more—helping them enhance and reimagine their work. As a consultant, she helps leaders and organizations draw on the science of arts and health to further their goals. This is one of those conversations that literally just scratches the surface of what is possible when considering how the arts influences our lives. It is an important conversation about why  we need to put art back into our daily routines as a prescription to wellbeing. ABOUT DAVID KEPRON:LinkedIn Profile: linkedin.com/in/david-kepron-9a1582bWebsites: https://www.davidkepron.com    (personal website)vmsd.com/taxonomy/term/8645  (Blog)Email: david.kepron@NXTLVLexperiencedesign.comTwitter: DavidKepronPersonal Instagram: https://www.instagram.com/davidkepron/NXTLVL Instagram: https://www.instagram.com/nxtlvl_experience_design/Bio:David Kepron is a multifaceted creative professional with a deep curiosity to understand ‘why', ‘what's now' and ‘what's next'. He brings together his background as an architect, artist, educator, author, podcast host and builder to the making of meaningful and empathically-focused, community-centric customer connections at brand experience places around the globe. David is a former VP - Global Design Strategies at Marriott International. While at Marriott, his focus was on the creation of compelling customer experiences within Marriott's “Premium Distinctive” segment which included: Westin, Renaissance, Le Meridien, Autograph Collection, Tribute Portfolio, Design Hotels and Gaylord hotels. In 2020 Kepron founded NXTLVL Experience Design, a strategy and design consultancy, where he combines his multidisciplinary approach to the creation of relevant brand engagements with his passion for social and cultural anthropology, neuroscience and emerging digital technologies. As a frequently requested international speaker at corporate events and international conferences focusing on CX, digital transformation, retail, hospitality, emerging technology, David shares his expertise on subjects ranging from consumer behaviors and trends, brain science and buying behavior, store design and visual merchandising, hotel design and strategy as well as creativity and innovation. In his talks, David shares visionary ideas on how brand strategy, brain science and emerging technologies are changing guest expectations about relationships they want to have with brands and how companies can remain relevant in a digitally enabled marketplace. David currently shares his experience and insight on various industry boards including: VMSD magazine's Editorial Advisory Board, the Interactive Customer Experience Association, Sign Research Foundation's Program Committee as well as the Center For Retail Transformation at George Mason University.He has held teaching positions at New York's Fashion Institute of Technology (F.I.T.), the Department of Architecture & Interior Design of Drexel University in Philadelphia, the Laboratory Institute of Merchandising (L.I.M.) in New York, the International Academy of Merchandising and Design in Montreal and he served as the Director of the Visual Merchandising Department at LaSalle International Fashion School (L.I.F.S.) in Singapore.  In 2014 Kepron published his first book titled: “Retail (r)Evolution: Why Creating Right-Brain Stores Will Shape the Future of Shopping in a Digitally Driven World” and he is currently working on his second book to be published soon. David also writes a popular blog called “Brain Food” which is published monthly on vmsd.com. ************************************************************************************************************************************The next level experience design podcast is presented by VMSD magazine and Smartwork Media. It is hosted and executive produced by David Kepron. Our original music and audio production by Kano Sound. The content of this podcast is copywrite to David Kepron and NXTLVL Experience Design. Any publication or rebroadcast of the content is prohibited without the expressed written consent of David Kepron and NXTLVL Experience Design.Make sure to tune in for more NXTLVL “Dialogues on DATA: Design Architecture Technology and the Arts” wherever you find your favorite podcasts and make sure to visit vmsd.com and look for the tab for the NXTLVL Experience Design podcast there too.

Genevieve Dunton, PhD, MPH is a professor of population and public health sciences and psychology, and chief of the Division of Health Behavior Research in the Department of Population and Public Health Sciences at Keck School of Medicine of USC. Dunton's research examines health behaviors related to chronic disease risk in children and adults, with a focus on physical activity and nutrition. Dunton is the Director of the USC REACH (Real-Time Eating Activity and Children's Health) lab, whose goals are to develop, test, and apply real-time data capture methodologies and applications, using smartphones and wearable sensors, to better understand the effects of psychological, social, and environmental factors on eating and physical activity. She is the PI on numerous studies funded by the National Institutes of Health and the American Cancer Society, author of over 250 peer-reviewed publications, and past Chair of the American Public Health Association Physical Activity Section. Dunton is also past Chair of the National Physical Activity Plan Public Health Sector Committee and past member of the National Academy of Sciences Committee on the Implementation of Physical Activity Surveillance Strategies. Learn more about this episode and others at pphs.usc.edu/podcastStay in the loop - subscribe to the Preventive Dose newsletter for monthly news straight to your inbox.Follow us on social - find us at @uscpphs Instagram TikTok Facebook LinkedIn X YouTube

Senate Committee on Indian Affairs Oversight Hearing titled, “Fentanyl in Native Communities: Native Perspectives on Addressing the Growing Crisis” Date: November 8, 2023 Time: 2:30pm Location: Dirksen Room: 628 Witnesses The Honorable Tony Hillaire Chairman Lummi Nation Bellingham, WA The Honorable Jamie S. Azure Chairman Turtle Mountain Band of Chippewa Indians of North Dakota Belcourt, ND The Honorable Bryce Kirk Councilman Assiniboine and Sioux Tribes of the Fort Peck Reservation Poplar, MT Dr. A. Aukahi Austin Seabury, Ph.D. Executive Director & Licensed Clinical Psychologist I Ola Lāhui, Inc. Honolulu, HI Mr. Eric M. Gettis Senior Vice President of Behavioral Health Southeast Alaska Regional Health Consortium Juneau, AK - Accompanied by Dr. Corey P. Cox, MD, Clinical Director for Addiction Services, Southeast Alaska Regional Health Consortium, Juneau, AK Dr. Claradina Soto, Ph.D. Associate Professor Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California Los Angeles, CA Committee Notice: https://www.indian.senate.gov/hearings/oversight-hearing-titled-fentanyl-in-native-communities-native-perspectives-on-addressing-the-growing-crisis/

Senate Committee on Indian Affairs Oversight Hearing titled, “Fentanyl in Native Communities: Native Perspectives on Addressing the Growing Crisis” Date: November 8, 2023 Time: 2:30pm Location: Dirksen Room: 628 Witnesses The Honorable Tony Hillaire Chairman Lummi Nation Bellingham, WA The Honorable Jamie S. Azure Chairman Turtle Mountain Band of Chippewa Indians of North Dakota Belcourt, ND The Honorable Bryce Kirk Councilman Assiniboine and Sioux Tribes of the Fort Peck Reservation Poplar, MT Dr. A. Aukahi Austin Seabury, Ph.D. Executive Director & Licensed Clinical Psychologist I Ola Lāhui, Inc. Honolulu, HI Mr. Eric M. Gettis Senior Vice President of Behavioral Health Southeast Alaska Regional Health Consortium Juneau, AK - Accompanied by Dr. Corey P. Cox, MD, Clinical Director for Addiction Services, Southeast Alaska Regional Health Consortium, Juneau, AK Dr. Claradina Soto, Ph.D. Associate Professor Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California Los Angeles, CA Committee Notice: https://www.indian.senate.gov/hearings/oversight-hearing-titled-fentanyl-in-native-communities-native-perspectives-on-addressing-the-growing-crisis/

Senate Committee on Indian Affairs Oversight Hearing titled, “Fentanyl in Native Communities: Native Perspectives on Addressing the Growing Crisis” Date: November 8, 2023 Time: 2:30pm Location: Dirksen Room: 628 Witnesses The Honorable Tony Hillaire Chairman Lummi Nation Bellingham, WA The Honorable Jamie S. Azure Chairman Turtle Mountain Band of Chippewa Indians of North Dakota Belcourt, ND The Honorable Bryce Kirk Councilman Assiniboine and Sioux Tribes of the Fort Peck Reservation Poplar, MT Dr. A. Aukahi Austin Seabury, Ph.D. Executive Director & Licensed Clinical Psychologist I Ola Lāhui, Inc. Honolulu, HI Mr. Eric M. Gettis Senior Vice President of Behavioral Health Southeast Alaska Regional Health Consortium Juneau, AK - Accompanied by Dr. Corey P. Cox, MD, Clinical Director for Addiction Services, Southeast Alaska Regional Health Consortium, Juneau, AK Dr. Claradina Soto, Ph.D. Associate Professor Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California Los Angeles, CA Committee Notice: https://www.indian.senate.gov/hearings/oversight-hearing-titled-fentanyl-in-native-communities-native-perspectives-on-addressing-the-growing-crisis/

Senate Committee on Indian Affairs Oversight Hearing titled, “Fentanyl in Native Communities: Native Perspectives on Addressing the Growing Crisis” Date: November 8, 2023 Time: 2:30pm Location: Dirksen Room: 628 Witnesses The Honorable Tony Hillaire Chairman Lummi Nation Bellingham, WA The Honorable Jamie S. Azure Chairman Turtle Mountain Band of Chippewa Indians of North Dakota Belcourt, ND The Honorable Bryce Kirk Councilman Assiniboine and Sioux Tribes of the Fort Peck Reservation Poplar, MT Dr. A. Aukahi Austin Seabury, Ph.D. Executive Director & Licensed Clinical Psychologist I Ola Lāhui, Inc. Honolulu, HI Mr. Eric M. Gettis Senior Vice President of Behavioral Health Southeast Alaska Regional Health Consortium Juneau, AK - Accompanied by Dr. Corey P. Cox, MD, Clinical Director for Addiction Services, Southeast Alaska Regional Health Consortium, Juneau, AK Dr. Claradina Soto, Ph.D. Associate Professor Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California Los Angeles, CA Committee Notice: https://www.indian.senate.gov/hearings/oversight-hearing-titled-fentanyl-in-native-communities-native-perspectives-on-addressing-the-growing-crisis/

Senate Committee on Indian Affairs Oversight Hearing titled, “Fentanyl in Native Communities: Native Perspectives on Addressing the Growing Crisis” Date: November 8, 2023 Time: 2:30pm Location: Dirksen Room: 628 Witnesses The Honorable Tony Hillaire Chairman Lummi Nation Bellingham, WA The Honorable Jamie S. Azure Chairman Turtle Mountain Band of Chippewa Indians of North Dakota Belcourt, ND The Honorable Bryce Kirk Councilman Assiniboine and Sioux Tribes of the Fort Peck Reservation Poplar, MT Dr. A. Aukahi Austin Seabury, Ph.D. Executive Director & Licensed Clinical Psychologist I Ola Lāhui, Inc. Honolulu, HI Mr. Eric M. Gettis Senior Vice President of Behavioral Health Southeast Alaska Regional Health Consortium Juneau, AK - Accompanied by Dr. Corey P. Cox, MD, Clinical Director for Addiction Services, Southeast Alaska Regional Health Consortium, Juneau, AK Dr. Claradina Soto, Ph.D. Associate Professor Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California Los Angeles, CA Committee Notice: https://www.indian.senate.gov/hearings/oversight-hearing-titled-fentanyl-in-native-communities-native-perspectives-on-addressing-the-growing-crisis/

Senate Committee on Indian Affairs Oversight Hearing titled, “Fentanyl in Native Communities: Native Perspectives on Addressing the Growing Crisis” Date: November 8, 2023 Time: 2:30pm Location: Dirksen Room: 628 Witnesses The Honorable Tony Hillaire Chairman Lummi Nation Bellingham, WA The Honorable Jamie S. Azure Chairman Turtle Mountain Band of Chippewa Indians of North Dakota Belcourt, ND The Honorable Bryce Kirk Councilman Assiniboine and Sioux Tribes of the Fort Peck Reservation Poplar, MT Dr. A. Aukahi Austin Seabury, Ph.D. Executive Director & Licensed Clinical Psychologist I Ola Lāhui, Inc. Honolulu, HI Mr. Eric M. Gettis Senior Vice President of Behavioral Health Southeast Alaska Regional Health Consortium Juneau, AK - Accompanied by Dr. Corey P. Cox, MD, Clinical Director for Addiction Services, Southeast Alaska Regional Health Consortium, Juneau, AK Dr. Claradina Soto, Ph.D. Associate Professor Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California Los Angeles, CA Committee Notice: https://www.indian.senate.gov/hearings/oversight-hearing-titled-fentanyl-in-native-communities-native-perspectives-on-addressing-the-growing-crisis/

Sara Schaefer discusses conflicts of interest and the Sunshine Act with attorneys John Hutchins, General Counsel of the American Academy of Neurology, and Mimi Riley, Professor of Law, Public Health Sciences, and Public Policy at the University of Virginia. Learn all about the levels of oversight, what kinds of things need to be disclosed, who discloses them and to whom, how they can impact your career, and where you might get tripped up. 

CPF Director Bob Shrum joins a panel of public health experts for a discussion on post-pandemic health inequities in America.   Featuring:  Sofia Gruskin: Director, USC Institute on Inequalities in Global Health  Sujeet Rao: Former Senior Policy Advisor, White House COVID-19 Response Team; Director, USC Dornsife Public Exchange Health and Wellbeing Practice  Dr. Bradley Stoner: Head of the Department of Public Health Sciences, Queens University; Former President of the American Sexually Transmitted Diseases Association Bob Shrum: Director, Center for the Political Future; Warschaw Chair in Practical Politics, USC Dornsife

CPF Director Bob Shrum joins a panel of public health experts for a discussion on post-pandemic health inequities in America.   Featuring:  Sofia Gruskin: Director, USC Institute on Inequalities in Global Health  Sujeet Rao: Former Senior Policy Advisor, White House COVID-19 Response Team; Director, USC Dornsife Public Exchange Health and Wellbeing Practice  Dr. Bradley Stoner: Head of the Department of Public Health Sciences, Queens University; Former President of the American Sexually Transmitted Diseases Association Bob Shrum: Director, Center for the Political Future; Warschaw Chair in Practical Politics, USC Dornsife